New Parkinson's drug enters early human safety trials
NCT ID NCT06565195
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 38 times
Summary
This early-stage study tests an experimental drug called LY3962681 in healthy volunteers and people with Parkinson's disease. The main goal is to check safety and how the body processes the drug. Participants receive one or two injections into the spinal fluid and are followed for up to a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Clinic PPD
RECRUITINGAustin, Texas, 78744-1625, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ehime University Hospital
NOT_YET_RECRUITINGTōon, Ehime, 791-0295, Japan
-
Oita University Hospital
NOT_YET_RECRUITINGYufu, Oita Prefecture, 879-5593, Japan
-
P-One Clinic, Keikokai Medical Corporation
RECRUITINGHachiōji, Tokyo, 192-0071, Japan
Conditions
Explore the condition pages connected to this study.